REVIEW
|
doi:10.20944/preprints202406.1677.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
Genomic profiling; Targeted therapies; Hypomethylating agents; Venetoclax-based combinations; Intensive chemotherapy; Transplantation; Clinical trials; Supportive care; Quality of life
Online: 24 June 2024 (12:04:02 CEST)